Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9Y483

Entry ID Method Resolution Chain Position Source
5XFR X-ray 225 A A/B 43-358 PDB
AF-Q9Y483-F1 Predicted AlphaFoldDB

322 variants for Q9Y483

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1350366036
CA341249145
5 T>I No ClinGen
gnomAD
rs762923381
CA952869
6 G>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA341249151
rs1265170548
7 A>T No ClinGen
gnomAD
rs764436816
CA952870
8 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA952871
rs774487835
11 L>V No ClinGen
ExAC
gnomAD
rs1183850511
CA341249189
13 H>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA952873
rs183737932
13 H>Y No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs750955831
CA952874
14 K>R No ClinGen
ExAC
gnomAD
CA952876
rs766773407
15 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA26782402
rs137905512
17 P>S No ClinGen
ESP
rs754440392
CA952878
19 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA952879
rs778633481
19 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA952880
COSM176178
rs189234488
20 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs746773581
CA952883
24 T>N No ClinGen
ExAC
rs1405923338
CA341249536
25 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA341249553
rs1285470717
26 T>I No ClinGen
TOPMed
gnomAD
CA26782415
rs983569243
27 S>F No ClinGen
TOPMed
rs1343847574
CA341249576
28 L>F No ClinGen
gnomAD
rs770953603
CA952884
29 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs941890613
CA26782421
30 K>R No ClinGen
Ensembl
TCGA novel 31 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs774575875
CA341249642
34 Q>H No ClinGen
ExAC
gnomAD
CA952887
rs768559181
34 Q>R No ClinGen
ExAC
CA341249655
rs1255287328
35 D>E No ClinGen
TOPMed
CA26782431
rs1054951816
37 H>L No ClinGen
gnomAD
CA341249709
rs1199845356
40 K>E No ClinGen
TOPMed
gnomAD
CA341249707
rs1199845356
40 K>Q No ClinGen
TOPMed
gnomAD
rs767694863
CA952890
40 K>R No ClinGen
ExAC
gnomAD
rs1479265285
CA341249748
43 A>T No ClinGen
gnomAD
CA341249762
rs1266008299
44 C>R No ClinGen
TOPMed
CA26782436
rs781395811
44 C>Y No ClinGen
Ensembl
CA341249771
rs1373161287
45 K>T No ClinGen
TOPMed
gnomAD
CA341249786
rs1476077167
46 F>L No ClinGen
gnomAD
rs760932337
CA952892
47 E>G No ClinGen
ExAC
gnomAD
rs1166723863
CA341249790
47 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA26782440
rs889679212
48 E>D No ClinGen
TOPMed
gnomAD
rs574583820
CA952893
50 Q>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA952894
rs754233865
57 S>L No ClinGen
ExAC
gnomAD
rs1296492211
CA341249970
61 F>I No ClinGen
gnomAD
TCGA novel 64 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754533215
CA952895
65 T>A No ClinGen
ExAC
gnomAD
rs371292695
CA341250033
65 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA952896
rs371292695
65 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs758169017
CA952898
66 I>V No ClinGen
ExAC
gnomAD
rs545847861
CA952921
69 I>M No ClinGen
1000Genomes
ExAC
CA341250150
rs1571235174
69 I>T No ClinGen
Ensembl
rs1160262651
CA341250145
69 I>V No ClinGen
gnomAD
rs1203929706
CA341250162
70 N>S No ClinGen
TOPMed
rs748291301
CA952924
71 I>M No ClinGen
ExAC
gnomAD
rs779953209
CA952923
71 I>T No ClinGen
ExAC
gnomAD
CA952922
rs147471959
71 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772072326
CA952925
72 L>S No ClinGen
ExAC
gnomAD
CA952926
rs777985864
74 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA341250291
rs1307477787
77 F>I No ClinGen
gnomAD
rs1307477787
CA341250296
77 F>V No ClinGen
gnomAD
rs149975527
CA952929
79 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs776901012
CA341250405
83 S>G No ClinGen
ExAC
gnomAD
TCGA novel 83 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs776901012
CA952930
83 S>R No ClinGen
ExAC
gnomAD
rs148700240
CA952931
89 L>H No ClinGen
ESP
ExAC
TCGA novel 102 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773778714
CA952954
103 M>V No ClinGen
ExAC
gnomAD
rs1424564680
CA341251912
106 T>I No ClinGen
gnomAD
CA341251949
rs1176419752
107 I>M No ClinGen
gnomAD
CA952955
rs146740892
107 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA341252115
rs1171133606
114 E>A No ClinGen
gnomAD
CA952956
rs144047097
115 A>P No ClinGen
ESP
ExAC
gnomAD
rs1307205499
CA341252178
117 N>D No ClinGen
gnomAD
rs1365921366
CA341252223
119 M>T No ClinGen
gnomAD
rs993057112
CA26783079
119 M>V No ClinGen
Ensembl
CA952957
rs772851960
121 I>M No ClinGen
ExAC
rs1272660051
CA341252286
123 D>V No ClinGen
gnomAD
rs1366365043
CA341252327
127 Q>E No ClinGen
gnomAD
rs772872603
CA952981
128 G>E No ClinGen
ExAC
gnomAD
TCGA novel 131 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341252422
rs1289492447
131 Q>R No ClinGen
gnomAD
rs1334438135
CA341252427
132 L>M No ClinGen
TOPMed
CA341252455
rs1218162567
134 H>Q No ClinGen
gnomAD
CA341252496
rs1309266161
139 D>G No ClinGen
TOPMed
CA952984
rs776459109
139 D>H No ClinGen
ExAC
gnomAD
VAR_054765
rs2815427
CA26783131
140 S>C No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA341252509
rs2815427
140 S>F No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs372072793
CA952985
140 S>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs2815427
CA341252507
140 S>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA341252512
rs1338261974
141 S>G No ClinGen
TOPMed
rs757299708
CA952988
141 S>I No ClinGen
ExAC
gnomAD
CA952989
rs149230809
142 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA952992
rs780407825
150 L>H No ClinGen
ExAC
gnomAD
rs1571239356
CA341252671
157 A>V No ClinGen
Ensembl
CA952994
rs376411392
158 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA952995
rs376411392
158 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1297904433
CA341252686
159 T>I No ClinGen
Ensembl
rs748639887
CA341252687
160 T>P No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 160 T>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748639887
CA952996
160 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs778241732
CA953017
170 P>L No ClinGen
ExAC
gnomAD
rs1472078029
CA341252820
171 N>D No ClinGen
gnomAD
rs146260596
CA953018
173 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA341252852
rs1378874743
174 A>T No ClinGen
gnomAD
rs1026397659
CA26783205
182 L>F No ClinGen
Ensembl
rs1370302054
CA341252956
184 Y>C No ClinGen
gnomAD
CA341252989
rs1325752303
187 A>V No ClinGen
gnomAD
rs1351234656
CA341252998
188 D>A No ClinGen
TOPMed
CA341253009
rs1571239815
190 E>K No ClinGen
Ensembl
CA26783207
rs866447049
193 A>V No ClinGen
Ensembl
rs1557553589
CA341253074
195 H>R No ClinGen
Ensembl
rs372949952
CA953022
198 N>S No ClinGen
ESP
ExAC
TCGA novel 199 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341253140
rs1232577397
201 Q>R No ClinGen
gnomAD
CA341253268
rs1437206110
CA341253269
212 W>C No ClinGen
gnomAD
rs1316688371
CA341253276
213 Y>C No ClinGen
gnomAD
CA26783571
rs934201351
214 L>S No ClinGen
gnomAD
rs780644573
CA953040
220 C>Y No ClinGen
ExAC
gnomAD
rs1051444513
CA26783574
221 K>R No ClinGen
TOPMed
gnomAD
rs1208832683
CA341253378
223 K>E No ClinGen
gnomAD
CA953041
rs745344955
223 K>M No ClinGen
ExAC
gnomAD
TCGA novel 225 W>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1247911428
CA341253455
229 A>V No ClinGen
gnomAD
CA341253497
rs1424813106
234 L>V No ClinGen
TOPMed
TCGA novel 237 P>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341253568
rs1186379928
241 G>R No ClinGen
TOPMed
TCGA novel 242 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA953071
rs779767918
243 R>S No ClinGen
ExAC
TOPMed
CA341253878
rs1466495426
245 Y>F No ClinGen
gnomAD
TCGA novel 246 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA953073
rs368305569
246 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA341253884
rs1304461614
246 T>S No ClinGen
gnomAD
CA341253906
rs530193073
248 I>L No ClinGen
1000Genomes
ExAC
gnomAD
rs530193073
CA953076
248 I>V No ClinGen
1000Genomes
ExAC
gnomAD
CA341253923
rs1571243218
249 C>F No ClinGen
Ensembl
rs1226145031
CA341253926
249 C>W No ClinGen
TOPMed
gnomAD
rs1571243238
CA341253937
251 V>F No ClinGen
Ensembl
rs548487482
CA953078
253 S>G No ClinGen
1000Genomes
ExAC
gnomAD
rs1483151567
CA341253971
254 S>F No ClinGen
gnomAD
rs1257528925
CA341253988
256 P>A No ClinGen
TOPMed
rs1257528925
CA341253987
256 P>S No ClinGen
TOPMed
rs775805505
CA953080
260 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA341254039
rs1181678784
261 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs998752706
CA26783731
262 L>V No ClinGen
TOPMed
gnomAD
CA953081
rs763125498
265 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA26783732
rs927714960
265 Q>K No ClinGen
Ensembl
CA341254167
rs1366236766
269 I>R No ClinGen
gnomAD
rs373446756
CA26783888
270 A>T No ClinGen
ESP
CA953096
COSM1748667
rs769950041
270 A>V urinary_tract [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA341254181
rs1571244469
271 H>Y No ClinGen
Ensembl
TCGA novel 276 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768928453
CA953099
280 I>V No ClinGen
ExAC
gnomAD
TCGA novel 292 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA26783894
rs79238228
302 R>K No ClinGen
Ensembl
CA341254761
rs1044683732
304 H>Q No ClinGen
TOPMed
gnomAD
rs1158325892
CA341254742
304 H>Y No ClinGen
gnomAD
CA341241738
rs1241312573
309 A>G No ClinGen
TOPMed
CA341241743
rs913784254
310 D>G No ClinGen
gnomAD
CA341241741
rs1266255498
310 D>H No ClinGen
gnomAD
CA26762349
rs913784254
310 D>V No ClinGen
gnomAD
rs201367461
CA26762359
314 S>C No ClinGen
Ensembl
rs1237861731
CA341241788
317 Y>H No ClinGen
gnomAD
rs376077677
CA953118
318 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs946750863
CA26762371
320 V>I No ClinGen
Ensembl
CA953120
rs748327882
328 K>N No ClinGen
ExAC
gnomAD
TCGA novel 336 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 336 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA26763941
rs759180756
COSM913368
349 R>C Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA341242288
rs1275420195
349 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA341242296
rs1571252389
350 V>F No ClinGen
Ensembl
rs1347047955
CA341242328
353 V>M No ClinGen
gnomAD
CA341242356
rs1217369650
355 P>Q No ClinGen
gnomAD
rs758605189
CA953142
356 N>D No ClinGen
ExAC
gnomAD
rs1206903203
CA341242385
357 V>G No ClinGen
gnomAD
CA341242379
rs1342584092
357 V>M No ClinGen
gnomAD
CA26763980
rs913484771
359 F>V No ClinGen
TOPMed
gnomAD
rs778052508
CA953143
365 P>R No ClinGen
ExAC
gnomAD
TCGA novel 369 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 373 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341242621
rs747339157
374 I>S No ClinGen
ExAC
TOPMed
CA953144
rs747339157
374 I>T No ClinGen
ExAC
TOPMed
rs1198970294
CA341242627
375 K>E No ClinGen
gnomAD
rs1205857215
CA341242669
378 K>R No ClinGen
TOPMed
CA953145
rs771270375
379 A>T No ClinGen
ExAC
gnomAD
CA953147
rs746340007
383 I>V No ClinGen
ExAC
gnomAD
CA341243191
rs1272978466
388 E>K No ClinGen
TOPMed
CA341243204
rs1187078244
390 S>G No ClinGen
gnomAD
CA953164
rs746215566
COSM682685
393 I>T lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1219730506
CA341243238
394 E>D No ClinGen
TOPMed
CA953168
rs538754400
396 K>N No ClinGen
1000Genomes
ExAC
gnomAD
rs759847587 397 G>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs759847587 397 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA341243261
rs1388721246
398 K>E No ClinGen
gnomAD
TCGA novel 399 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748757631
CA953170
401 S>A No ClinGen
ExAC
TOPMed
gnomAD
CA953171
rs768160286
401 S>F No ClinGen
ExAC
gnomAD
CA26767818
rs899561841
403 G>V No ClinGen
TOPMed
rs1275020349
COSM3419585
CA341243301
404 R>C large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA953173
rs375713787
404 R>H No ClinGen
ESP
ExAC
gnomAD
rs773047530
CA953175
408 P>S No ClinGen
ExAC
gnomAD
CA953176
rs146904489
409 Y>C No ClinGen
1000Genomes
ESP
ExAC
gnomAD
CA341243330
rs146904489
409 Y>S No ClinGen
1000Genomes
ESP
ExAC
gnomAD
rs753751265
CA341243338
410 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs753751265
CA953178
410 T>K No ClinGen
ExAC
TOPMed
gnomAD
rs1324997976
CA341243343
411 R>I No ClinGen
TOPMed
rs762966323
CA953179
411 R>S No ClinGen
ExAC
gnomAD
rs1466057771
CA341243346
412 K>E No ClinGen
TOPMed
TCGA novel 412 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA953180
rs764195493
412 K>T No ClinGen
ExAC
gnomAD
TCGA novel
CA341243360
rs1261537761
413 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
gnomAD
CA341243368
rs1424732864
415 Q>K No ClinGen
TOPMed
gnomAD
rs751564516
CA953181
416 K>N No ClinGen
ExAC
gnomAD
TCGA novel 418 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA953182
rs757605105
421 L>F No ClinGen
ExAC
gnomAD
CA26767899
rs141766157
422 L>W No ClinGen
ESP
TOPMed
CA953200
rs761914281
423 D>G No ClinGen
ExAC
gnomAD
CA953199
rs554881537
423 D>N No ClinGen
1000Genomes
ExAC
gnomAD
rs767914322
CA953201
424 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs750655207
CA953202
425 E>K No ClinGen
ExAC
gnomAD
rs1313302940
CA341243550
428 S>T No ClinGen
TOPMed
gnomAD
CA341243573
rs1303971285
429 E>A No ClinGen
gnomAD
rs1236208235
CA341243564
429 E>K No ClinGen
gnomAD
rs1278664913
CA341243585
430 N>D No ClinGen
gnomAD
CA26768159
rs267598771
431 P>S No ClinGen
Ensembl
rs1178383773
CA341243619
433 L>S No ClinGen
TOPMed
rs756589883
CA341243664
436 P>A No ClinGen
ExAC
gnomAD
rs756589883
CA953204
436 P>S No ClinGen
ExAC
gnomAD
rs576246655
CA953206
439 I>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA953205
rs138260646
439 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 439 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs766456138
CA953223
441 R>K No ClinGen
ExAC
gnomAD
CA953224
rs754235699
443 E>* No ClinGen
ExAC
gnomAD
CA953225
rs541149620
446 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs375212833
CA953226
447 H>Y No ClinGen
ESP
ExAC
gnomAD
CA26768468
rs754636918
449 S>A No ClinGen
Ensembl
rs1039525707
CA26768472
449 S>F No ClinGen
TOPMed
rs143286394
CA953228
450 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA953229
rs777294935
451 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA953230
rs746471855
454 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA953231
rs756944942
457 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA953233
rs745739457
458 G>V No ClinGen
ExAC
gnomAD
CA341243901
rs1214252316
459 A>S No ClinGen
TOPMed
gnomAD
rs1014597465
CA341243909
460 S>C No ClinGen
TOPMed
gnomAD
rs1014597465
CA26768519
460 S>F No ClinGen
TOPMed
gnomAD
CA953234
rs769458705
461 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA953235
rs372898714
462 A>T No ClinGen
ESP
ExAC
gnomAD
CA953236
rs749273526
462 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA341243936
rs773441104
463 K>E No ClinGen
ExAC
TOPMed
gnomAD
CA953238
rs773441104
463 K>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1474285282
CA341243986
466 T>A No ClinGen
gnomAD
rs760606327
CA953239
467 S>L No ClinGen
ExAC
gnomAD
CA26768587
rs920530055
469 S>C No ClinGen
TOPMed
rs920530055
CA341244027
469 S>G No ClinGen
TOPMed
rs141909054
CA953241
469 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs141909054
CA341244034
469 S>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA341244053
rs1354860391
470 I>S No ClinGen
TOPMed
CA341244068
rs1462063634
471 S>Y No ClinGen
TOPMed
gnomAD
TCGA novel 474 Y>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1169413110
CA341244126
475 G>A No ClinGen
gnomAD
CA953261
rs747172805
478 D>H No ClinGen
ExAC
TOPMed
gnomAD
rs1411724423
CA341244496
479 S>F No ClinGen
gnomAD
rs1348459071
CA341244537
482 R>S No ClinGen
TOPMed
gnomAD
TCGA novel 482 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770893619
CA953263
483 T>K No ClinGen
ExAC
TOPMed
gnomAD
rs770893619
CA953262
483 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs769952594
COSM3741433
CA953265
484 R>C liver [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA953266
rs775843760
484 R>H No ClinGen
ExAC
gnomAD
CA341244561
rs775843760
484 R>P No ClinGen
ExAC
gnomAD
rs763234602
CA953267
488 S>C No ClinGen
ExAC
gnomAD
TCGA novel 488 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA26770954
rs927209944
489 W>S No ClinGen
TOPMed
gnomAD
rs1170694359
CA341244629
490 P>L No ClinGen
TOPMed
CA953268
rs764649997
493 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs751992913
CA953269
495 H>N No ClinGen
ExAC
gnomAD
rs1397317301
CA341244704
496 L>V No ClinGen
gnomAD
CA953271
rs139375903
497 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA953270
rs1046801
497 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA953273
rs749903364
498 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA341244739
rs1411801351
498 R>T No ClinGen
gnomAD
rs755739276
CA953274
500 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs943981469
CA26771016
502 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA341244824
rs1277007961
502 R>H No ClinGen
TOPMed
rs943981469
CA26771019
502 R>S No ClinGen
TOPMed
rs1441447157
CA341244849
504 P>L No ClinGen
gnomAD
rs1352120665
CA341244851
505 R>G No ClinGen
TOPMed
COSM682684
rs753754787
CA953276
511 Q>H lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
rs200133449
CA953275
511 Q>R No ClinGen
ExAC
gnomAD
TCGA novel 515 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs868639197
CA26771036
515 I>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA953278
rs754808853
518 D>G No ClinGen
ExAC
CA953279
rs779044413
519 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs748005336
CA953280
520 E>K No ClinGen
ExAC
gnomAD
rs141738080
CA953281
521 G>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs781152693
CA953283
522 K>E No ClinGen
ExAC
rs781152693
CA953282
522 K>Q No ClinGen
ExAC
CA341245106
rs1331996088
522 K>R No ClinGen
TOPMed
CA341245151
rs1200280911
525 Y>D No ClinGen
gnomAD
CA341245166
rs1255430118
525 Y>F No ClinGen
gnomAD
CA26771123
rs112099255
528 D>G No ClinGen
TOPMed
rs918600672
CA26771131
531 N>D No ClinGen
TOPMed
gnomAD
CA341245299
rs1391127271
532 T>P No ClinGen
gnomAD
CA341245362
rs1224001064
535 L>P No ClinGen
Ensembl
CA953285
rs775682377
539 A>G No ClinGen
ExAC
gnomAD
TCGA novel 539 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1411352685
CA341245427
540 D>G No ClinGen
TOPMed
rs371327740
CA26771134
540 D>N No ClinGen
ESP
TOPMed
CA341245445
rs1571259275
541 Q>R No ClinGen
Ensembl
CA341245453
rs1395908728
542 E>K No ClinGen
gnomAD
rs1406020444
CA341245479
544 Q>K No ClinGen
gnomAD
rs768981663
CA953287
546 N>H No ClinGen
ExAC
gnomAD
CA953288
rs77900924
546 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs768013188
CA953290
550 N>Y No ClinGen
ExAC
TOPMed
gnomAD
CA26771215
rs865794919
553 T>N No ClinGen
Ensembl
CA341245693
rs1276331915
558 A>T No ClinGen
gnomAD
rs1357480461
CA341245707
559 A>S No ClinGen
TOPMed
gnomAD
rs1207427135
CA341245811
565 G>D No ClinGen
TOPMed
CA26771258
rs1001044433
567 K>N No ClinGen
TOPMed
gnomAD
rs778604065
CA953296
567 K>Q No ClinGen
ExAC
gnomAD
rs1356266521
CA740425021
568 Y>* No ClinGen
Ensembl
rs752487729
CA953297
569 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs777697964
CA953299
573 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs777697964
CA341245945
573 R>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 577 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA953300
rs745998380
580 K>R No ClinGen
ExAC
gnomAD
rs1415709116
CA341246056
583 Y>H No ClinGen
gnomAD
CA26771294
rs867752694
585 V>M No ClinGen
Ensembl
rs1365696331
CA341246178
592 A>V No ClinGen
TOPMed

No associated diseases with Q9Y483

No regional properties for Q9Y483

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q9Y483

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Localizes to chromatin as part of the PRC2 complex
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
ESC/E(Z) complex A multimeric protein complex that can methylate lysine-27 and lysine-9 residues of histone H3. In Drosophila the core subunits of the complex include ESC, E(Z), CAF1 (NURF-55) and SU(Z)12. In mammals the core subunits of the complex include EED, EZH2, SUZ12 and RBBP4.
focal adhesion A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

6 GO annotations of molecular function

Name Definition
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
metal ion binding Binding to a metal ion.
methylated histone binding Binding to a histone in which a residue has been modified by methylation.
RNA polymerase II transcription regulatory region sequence-specific DNA binding Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
transcription corepressor binding Binding to a transcription corepressor, a protein involved in negative regulation of transcription via protein-protein interactions with transcription factors and other proteins that negatively regulate transcription. Transcription corepressors do not bind DNA directly, but rather mediate protein-protein interactions between repressing transcription factors and the basal transcription machinery.

10 GO annotations of biological process

Name Definition
cellular response to leukemia inhibitory factor Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
chromatin organization The assembly or remodeling of chromatin composed of DNA complexed with histones, other associated proteins, and sometimes RNA.
negative regulation of histone H3-K27 methylation Any process that decreases the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of histone H3-K27 methylation Any process that increases the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
regulation of DNA-templated transcription Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
segment specification The process in which segments assume individual identities; exemplified in insects by the actions of the products of the homeotic genes.
stem cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
stem cell population maintenance The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O43189 PHF1 PHD finger protein 1 Homo sapiens (Human) PR
Q9Z1B8 Phf1 PHD finger protein 1 Mus musculus (Mouse) PR
Q02395 Mtf2 Metal-response element-binding transcription factor 2 Mus musculus (Mouse) PR
10 20 30 40 50 60
MRDSTGAGNS LVHKRSPLRR NQKTPTSLTK LSLQDGHKAK KPACKFEEGQ DVLARWSDGL
70 80 90 100 110 120
FYLGTIKKIN ILKQSCFIIF EDSSKSWVLW KDIQTGATGS GEMVCTICQE EYSEAPNEMV
130 140 150 160 170 180
ICDKCGQGYH QLCHTPHIDS SVIDSDEKWL CRQCVFATTT KRGGALKKGP NAKALQVMKQ
190 200 210 220 230 240
TLPYSVADLE WDAGHKTNVQ QCYCYCGGPG DWYLKMLQCC KCKQWFHEAC VQCLQKPMLF
250 260 270 280 290 300
GDRFYTFICS VCSSGPEYLK RLPLQWVDIA HLCLYNLSVI HKKKYFDSEL ELMTYINENW
310 320 330 340 350 360
DRLHPGELAD TPKSERYEHV LEALNDYKTM FMSGKEIKKK KHLFGLRIRV PPVPPNVAFK
370 380 390 400 410 420
AEKEPEGTSH EFKIKGRKAS KPISDSREVS NGIEKKGKKK SVGRPPGPYT RKMIQKTAEP
430 440 450 460 470 480
LLDKESISEN PTLDLPCSIG RTEGTAHSSN TSDVDFTGAS SAKETTSSSI SRHYGLSDSR
490 500 510 520 530 540
KRTRTGRSWP AAIPHLRRRR GRLPRRALQT QNSEIVKDDE GKEDYQFDEL NTEILNNLAD
550 560 570 580 590
QELQLNHLKN SITSYFGAAG RIACGEKYRV LARRVTLDGK VQYLVEWEGA TAS